Section Arrow
ALEC.NASDAQ
- Alector
Quotes are at least 15-min delayed:2026/04/02 07:31 EDT
Pre Market
Last
 2.41
-0.12 (-4.74%)
Bid
2.28
Ask
2.53
High 2.5 
Low 2.3275 
Volume 2.19K 
Regular Hours (Closed)
Last
 2.53
+0.38 (+17.67%)
Day High 
2.635 
Prev. Close
2.15 
1-M High
2.65 
Volume 
3.30M 
Bid
2.28
Ask
2.53
Day Low
2.16 
Open
2.18 
1-M Low
1.89 
Market Cap 
237.28M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 2.08 
20-SMA 2.13 
50-SMA 2.06 
52-W High 3.3999 
52-W Low 0.87 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.39/-1.51
Enterprise Value
264.09M
Balance Sheet
Book Value Per Share
0.28
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
21.05M
Operating Revenue Per Share
0.87
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CYCNCyclerion Therapeutics6.38+4.83+311.61%-- 
Pre Market 5.5595 -0.8205 -12.86%
ELABPmgc Holdings Inc14+8.01+133.72%0PE
Pre Market 4.61 -9.39 -67.07%
IOBTIO Biotech0.0437-0.015-25.55%-- 
Pre Market 0.0396 -0.0041 -9.38%
APLSApellis Pharmaceuticals40.39+0.16+0.40%224.11PE
Pre Market 40.3377 -0.0523 -0.13%
GERNGeron Corp1.66+0.17+11.41%-- 
Pre Market 1.5762 -0.0838 -5.05%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.